Bremmer MA, Beekman AT, Deeg DJ, Penninx BW, Dik MG, Hack CE, Hoogendijk WJ (2008). Inflammatory markers in late-life depression: results from a population-based study. Journal of Affective Disorders 106, 249–255.
Brunner E, Davey Smith G, Marmot M, Canner R, Beksinska M, O'Brien J (1996). Childhood social circumstances and psychosocial and behavioural factors as determinants of plasma fibrinogen. Lancet 347, 1008–1013.
Brunner E, Shipley MJ, Blane D, Smith GD, Marmot MG (1999). When does cardiovascular risk start? Past and present socioeconomic circumstances and risk factors in adulthood. Journal of Epidemiology and Community Health 53, 757–764.
Carney RM, Freedland KE, Miller GE, Jaffe AS (2002). Depression as a risk factor for cardiac mortality and morbidity: a review of potential mechanisms. Journal of Psychosomatic Research 53, 897–902.
Cyranowski JM, Marsland AL, Bromberger JT, Whiteside TL, Chang Y, Matthews KA (2007). Depressive symptoms and production of proinflammatory cytokines by peripheral blood mononuclear cells stimulated in vitro. Brain, Behavior, and Immunity 21, 229–237.
Danese A, Pariante CA, Caspi A, Taylor A, Poulton R (2007). Childhood maltreatment predicts adult inflammation in a life-course study. Proceedings of the National Academy of Sciences USA 104, 1319–1324.
Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, Rumley A, Lowe GD, Pepys MB, Gudnason V (2004). C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. New England Journal of Medicine 350, 1387–1397.
Dantzer R, Castanon N, Lestage J, Moreau M, Capuron L (2006). Inflammation, sickness behaviour and depression. In Depression and Physical Illness (ed. Steptoe A.), pp. 265–279. Cambridge University Press: Cambridge.
Dantzer R, Kelley KW (2007). Twenty years of research on cytokine-induced sickness behavior. Brain, Behavior, and Immunity 21, 153–160.
Dentino AN, Pieper CF, Rao MK, Currie MS, Harris T, Blazer DG, Cohen HJ (1999). Association of interleukin-6 and other biologic variables with depression in older people living in the community. Journal of the American Geriatrics Society 47, 6–11.
Elovainio M, Keltikangas-Jarvinen L, Pulkki-Raback L, Kivimaki M, Puttonen S, Viikari L, Rasanen L, Mansikkaniemi K, Viikari J, Raitakari OT (2006). Depressive symptoms and C-reactive protein: the Cardiovascular Risk in Young Finns Study. Psychological Medicine 36, 797–805.
Fogel J, Eaton WW, Ford DE (2006). Minor depression as a predictor of the first onset of major depressive disorder over a 15-year follow-up. Acta Psychiatrica Scandinavica 113, 36–43.
Ford DE, Erlinger TP (2004). Depression and C-reactive protein in US adults: data from the Third National Health and Nutrition Examination Survey. Archives of Internal Medicine 164, 1010–1014.
Frasure-Smith N, Lesperance F (2006). Recent evidence linking coronary heart disease and depression. Canadian Journal of Psychiatry 51, 730–737.
Gabay C, Kushner I (1999). Acute-phase proteins and other systemic responses to inflammation. New England Journal of Medicine 340, 448–454.
Goldberg D (1972). The Detection of Psychiatric Illness by Questionnaire. Maudsley Monograph no. 21. Oxford University Press: London.
Goldberg DP, Hillier VF (1979). A scaled version of the General Health Questionnaire. Psychological Medicine 9, 139–145.
Kiecolt-Glaser JK, McGuire L, Robles TF, Glaser R (2002). Emotions, morbidity, and mortality: new perspectives from psychoneuroimmunology. Annual Review of Psychology 53, 83–107.
Kingman A, Zion G (1994). Some power considerations when deciding to use transformations. Statistics in Medicine 13, 769–783.
Kumari M, Head J, Marmot M (2004). Prospective study of social and other risk factors for incidence of type 2 diabetes in the Whitehall II study. Archives of Internal Medicine 164, 1873–1880.
Kuo HK, Yen CJ, Chang CH, Kuo CK, Chen JH, Sorond F (2005). Relation of C-reactive protein to stroke, cognitive disorders, and depression in the general population: systematic review and meta-analysis. Lancet Neurology 4, 371–380.
Kuper H, Marmot M (2003). Job strain, job demands, decision latitude, and risk of coronary heart disease within the Whitehall II study. Journal of Epidemiology and Community Health 57, 147–153.
Li CY, Sung FC (1999). A review of the healthy worker effect in occupational epidemiology. Occupational Medicine 49, 225–229.
Liukkonen T, Silvennoinen-Kassinen S, Jokelainen J, Rasanen P, Leinonen M, Meyer-Rochow VB, Timonen M (2006). The association between C-reactive protein levels and depression: results from the northern Finland 1966 birth cohort study. Biological Psychiatry 60, 825–830.
Maes M, Meltzer HY, Bosmans E, Bergmans R, Vandoolaeghe E, Ranjan R, Desnyder R (1995 a). Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression. Journal of Affective Disorders 34, 301–309.
Maes M, Vandoolaeghe E, Ranjan R, Bosmans E, Bergmans R, Desnyder R (1995 b). Increased serum interleukin-1-receptor-antagonist concentrations in major depression. Journal of Affective Disorders 36, 29–36.
Mancini GB, Dahlof B, Diez J (2004). Surrogate markers for cardiovascular disease: structural markers. Circulation 109 (Suppl. 1), IV22–IV30.
Marmot M, Brunner E (2005). Cohort profile: the Whitehall II study. International Journal of Epidemiology 34, 251–256.
Marmot MG, Smith GD, Stansfeld S, Patel C, North F, Head J, White I, Brunner E, Feeney A (1991). Health inequalities among British civil servants: the Whitehall II study. Lancet 337, 1387–1393.
Myers GL, Rifai N, Tracy RP, Roberts WL, Alexander RW, Biasucci LM, Catravas JD, Cole TG, Cooper GR, Khan BV, Kimberly MM, Stein EA, Taubert KA, Warnick GR, Waymack PP (2004). CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: report from the laboratory science discussion group. Circulation 110, e545–e549.
Nicholson A, Fuhrer R, Marmot M (2005). Psychological distress as a predictor of CHD events in men: the effect of persistence and components of risk. Psychosomatic Medicine 67, 522–530.
Pace TW, Mletzko TC, Alagbe O, Musselman DL, Nemeroff CB, Miller AH, Heim CM (2006). Increased stress-induced inflammatory responses in male patients with major depression and increased early life stress. American Journal of Psychiatry 163, 1630–1633.
Patel V, Araya R, Chowdhary N, King M, Kirkwood B, Nayak S, Simon G, Weiss HA (2008). Detecting common mental disorders in primary care in India: a comparison of five screening questionnaires. Psychological Medicine 38, 221–228.
Penninx BW, Kritchevsky SB, Yaffe K, Newman AB, Simonsick EM, Rubin S, Ferrucci L, Harris T, Pahor M (2003). Inflammatory markers and depressed mood in older persons: results from the Health, Aging and Body Composition study. Biological Psychiatry 54, 566–572.
Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM (2001). C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. Journal of the American Medical Association 286, 327–334.
Raison CL, Capuron L, Miller AH (2006). Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends in Immunology 27, 24–31.
Ranjit N, Diez-Roux AV, Shea S, Cushman M, Seeman T, Jackson SA, Ni H (2007). Psychosocial factors and inflammation in the multi-ethnic study of atherosclerosis. Archives of Internal Medicine 167, 174–181.
Rasul F, Stansfeld SA, Smith GD, Shlomo YB, Gallacher J (2007). Psychological distress, physical illness and risk of myocardial infarction in the Caerphilly study. Psychological Medicine 37, 1305–1313.
Ross R (1999). Atherosclerosis – an inflammatory disease. New England Journal of Medicine 340, 115–126.
Royal College of Physicians, Royal College of Psychiatrists, Royal College of General Practitioners (1995). Alcohol and the Heart in Perspective: Sensible Limits Reaffirmed. Royal College of Physicians, Royal College of Psychiatrists, Royal College of General Practitioners: London.
Sothern RB, Roitman-Johnson B, Kanabrocki EL, Yager JG, Roodell MM, Weatherbee JA, Young MR, Nenchausky BM, Scheving LE (1995). Circadian characteristics of circulating interleukin-6 in men. Journal of Allergy and Clinical Immunology 95, 1029–1035.
Stansfeld SA, Head J, Fuhrer R, Wardle J, Cattell V (2003). Social inequalities in depressive symptoms and physical functioning in the Whitehall II study: exploring a common cause explanation. Journal of Epidemiology and Community Health 57, 361–367.
Stansfeld SA, Marmot MG (1992). Social class and minor psychiatric disorder in British civil servants: a validated screening survey using the General Health Questionnaire. Psychological Medicine 22, 739–749.
Stewart JC, Janicki DL, Muldoon MF, Sutton-Tyrrell K, Kamarck TW (2007). Negative emotions and 3-year progression of subclinical atherosclerosis. Archives of General Psychiatry 64, 225–233.
Tiemeier H, Hofman A, van Tuijl HR, Kiliaan AJ, Meijer J, Breteler MM (2003). Inflammatory proteins and depression in the elderly. Epidemiology 14, 103–107.
Watson R, Deary IJ, Shipley B (2008). A hierarchy of distress: Mokken scaling of the GHQ-30. Psychological Medicine 38, 575–579.
Wener MH, Daum PR, McQuillan GM (2000). The influence of age, sex, and race on the upper reference limit of serum C-reactive protein concentration. Journal of Rheumatology 27, 2351–2359.
Wichers M, Maes M (2002). The psychoneuroimmuno-pathophysiology of cytokine-induced depression in humans. International Journal of Neuropsychopharmacology 5, 375–388.
Woodward M, Rumley A, Lowe GD, Tunstall-Pedoe H (2003). C-reactive protein: associations with haematological variables, cardiovascular risk factors and prevalent cardiovascular disease. British Journal of Haematology 122, 135–141.
Woodward M, Rumley A, Tunstall-Pedoe H, Lowe GD (1999). Associations of blood rheology and interleukin-6 with cardiovascular risk factors and prevalent cardiovascular disease. British Journal of Haematology 104, 246–257.
Yaffe K, Kanaya A, Lindquist K, Simonsick EM, Harris T, Shorr RI, Tylavsky FA, Newman AB (2004). The metabolic syndrome, inflammation, and risk of cognitive decline. Journal of the American Medical Association 292, 2237–2242.